PALISADE BIO, INC.: total assets
Total assets for PALISADE BIO, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All PALISADE BIO, INC. financial histories
What this measure means
Resources recognized on the balance sheet. Book assets are not the market value of the business.
Exact concept: us-gaap:Assets. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2010-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 134,344,000 | USD | 2026-03-20 | 10-K · 0001357459-26-000004 |
| At date | 2024-12-31 | 10,880,000 | USD | 2026-03-20 | 10-K · 0001357459-26-000004 |
| At date | 2023-12-31 | 14,052,000 | USD | 2025-03-24 | 10-K · 0000950170-25-043859 |
| At date | 2022-12-31 | 15,763,000 | USD | 2024-03-26 | 10-K · 0000950170-24-036402 |
| At date | 2021-12-31 | 12,512,000 | USD | 2023-03-22 | 10-K · 0000950170-23-009226 |
| At date | 2020-12-31 | 3,019,000 | USD | 2022-03-17 | 10-K · 0000950170-22-004093 |
| At date | 2019-12-31 | 6,583,889 | USD | 2021-03-22 | 10-K · 0001171843-21-001965 |
| At date | 2018-12-31 | 7,684,450 | USD | 2020-03-27 | 10-K · 0001171843-20-002061 |
| At date | 2017-12-31 | 13,884,456 | USD | 2019-03-22 | 10-K · 0001171843-19-001917 |
| At date | 2016-12-31 | 22,604,328 | USD | 2018-04-02 | 10-K · 0001171843-18-002404 |
| At date | 2015-12-31 | 14,949,548 | USD | 2017-03-23 | 10-K · 0001171843-17-001704 |
| At date | 2014-12-31 | 29,844,075 | USD | 2016-03-14 | 10-K · 0001144204-16-087765 |
| At date | 2013-12-31 | 19,413,536 | USD | 2015-03-16 | 10-K · 0001144204-15-016085 |
| At date | 2012-12-31 | 8,750,079 | USD | 2014-03-10 | 10-K · 0001144204-14-014279 |
| At date | 2011-12-31 | 4,086,177 | USD | 2013-03-15 | 10-K · 0001144204-13-015444 |
| At date | 2010-12-31 | 10,591,360 | USD | 2012-03-30 | 10-K · 0001144204-12-018248 |
Related financial histories
- PALISADE BIO, INC.: total liabilities
- PALISADE BIO, INC.: stockholders equity
- PALISADE BIO, INC.: cash and cash equivalents
- PALISADE BIO, INC.: net income or loss
- PALISADE BIO, INC.: operating cash flow
- PALISADE BIO, INC.: capital expenditure payments
- PALISADE BIO, INC.: revenue
- PALISADE BIO, INC.: contract revenue excluding tax
- PALISADE BIO, INC.: financing cash flow
- PALISADE BIO, INC.: investing cash flow
- PALISADE BIO, INC.: retained earnings or deficit
- PALISADE BIO, INC.: basic weighted-average shares
- PALISADE BIO, INC.: diluted weighted-average shares
- PALISADE BIO, INC.: basic earnings per share
- PALISADE BIO, INC.: diluted earnings per share
- PALISADE BIO, INC.: income tax expense or benefit
- PALISADE BIO, INC.: net property, plant and equipment
- PALISADE BIO, INC.: share-based compensation expense
- PALISADE BIO, INC.: operating income or loss
- PALISADE BIO, INC.: current assets
- PALISADE BIO, INC.: interest expense
- PALISADE BIO, INC.: current liabilities
- PALISADE BIO, INC.: current accounts payable
- PALISADE BIO, INC.: net finite-lived intangible assets
- PALISADE BIO, INC.: net current accounts receivable
- PALISADE BIO, INC.: operating expenses
- PALISADE BIO, INC.: research and development expense
Inspect the source
- Entity
- PALISADE BIO, INC. / CIK 0001357459
- Captured
- 2026-09-20T07:55:46.162Z
- SEC response SHA-256
1d4973c07aed8ad894103731546b55683b331acdd472b37e4b33a98a2f63a74c
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001357459.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))